afatinib

E2190163 UNEXPLORED

Afatinib is an oral tyrosine kinase inhibitor used primarily to treat certain non-small cell lung cancers driven by epidermal growth factor receptor (EGFR) mutations.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label	Occurrences
afatinib canonical	1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

EGFR → targetOfDrug → afatinib ⓘ